Allen Kaplan to Animals
This is a "connection" page, showing publications Allen Kaplan has written about Animals.
Connection Strength
0.528
-
Hereditary angioedema: Investigational therapies and future research. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S51-S54.
Score: 0.053
-
Preventing anaphylaxis fatalities: Should we target bradykinin? J Allergy Clin Immunol. 2020 05; 145(5):1365-1366.
Score: 0.051
-
Treatment of urticaria: a clinical and mechanistic approach. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):387-392.
Score: 0.049
-
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
Score: 0.041
-
The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):444-53.
Score: 0.035
-
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014; 121:41-89.
Score: 0.033
-
The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9.
Score: 0.026
-
Kinins, airway obstruction, and anaphylaxis. Chem Immunol Allergy. 2010; 95:67-84.
Score: 0.026
-
Kinin formation in C1 inhibitor deficiency. J Allergy Clin Immunol. 2010 Jun; 125(6):1411-2; author reply 1412.
Score: 0.026
-
Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005; 86:159-208.
Score: 0.018
-
Protease activity in single-chain prekallikrein. Blood. 2020 02 20; 135(8):558-567.
Score: 0.013
-
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999 Sep; 43(2-3):203-10.
Score: 0.012
-
Chemokines and the late-phase reaction. Allergy. 1998; 53(45 Suppl):27-32.
Score: 0.011
-
Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
Score: 0.010
-
The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv Immunol. 1997; 66:225-72.
Score: 0.010
-
The complement and contact activation systems: partnership in pathogenesis beyond angioedema. Immunol Rev. 2016 11; 274(1):281-289.
Score: 0.010
-
Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5.
Score: 0.009
-
Neurotropin promotes NGF signaling through interaction of GM1 ganglioside with Trk neurotrophin receptor in PC12 cells. Brain Res. 2015 Jan 30; 1596:13-21.
Score: 0.009
-
Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501.
Score: 0.009
-
Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012. Inflamm Res. 2014 Mar; 63(3):173-8.
Score: 0.008
-
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43.
Score: 0.008
-
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol. 1992 Mar 17; 43(6):1361-9.
Score: 0.007
-
Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin. Mol Cell Neurosci. 2010 Nov; 45(3):226-33.
Score: 0.006
-
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. 1989 Aug 01; 74(2):695-702.
Score: 0.006
-
Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. 1989 Apr 21; 119(1):19-25.
Score: 0.006
-
Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. Biochem Pharmacol. 1989 Mar 15; 38(6):993-1000.
Score: 0.006
-
Mediators of inflammation: an overview. Methods Enzymol. 1988; 163:3-23.
Score: 0.005
-
Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci. 1982; 389:25-38.
Score: 0.004
-
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001 Sep; 108(3):394-401.
Score: 0.004
-
Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5.
Score: 0.004
-
Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med. 1981 Mar 01; 153(3):665-76.
Score: 0.003
-
Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998; 16(4):403-29.
Score: 0.003
-
Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin Exp Allergy. 1997 Jun; 27(6):653-63.
Score: 0.003
-
The kallikrein-kinin system in inflammation. Adv Exp Med Biol. 1989; 247A:125-36.
Score: 0.001
-
Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
Score: 0.001
-
Quantitative assays of pharmacologic aerosols used in studying asthma. J Allergy Clin Immunol. 1985 Oct; 76(4):605-9.
Score: 0.001
-
Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin. J Clin Invest. 1985 Aug; 76(2):413-9.
Score: 0.001